The present invention relates to a preparation for oral administration containing lignin for use in the prevention and/or treatment of obesity and/or obesity-induced metabolic complications (abdominal fat accumulation, glucose intolerance, hepatic steatosis) in humans suffering from obesity. It further relates to the use of the preparation containing lignin as a food supplement to reduce overweight and/or to improve the overweight-induced metabolic complications in overweight individuals.
